Drug Type circular RNA |
Synonyms- |
Target |
Action inhibitors |
Mechanism NKX2-1 inhibitors(NK2 homeobox 1 inhibitors), SOX2 inhibitors(SRY-box transcription factor 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuroendocrine Tumors | Preclinical | China | 17 Apr 2025 | |
Neuroendocrine Tumors | Preclinical | Canada | 17 Apr 2025 | |
Neuroendocrine Tumors | Preclinical | China | 17 Apr 2025 | |
Neuroendocrine Tumors | Preclinical | Canada | 17 Apr 2025 |